The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
What do you want to do about it?
Agronomics has so much potential as a vehicle for investing in the future agrarian revolution, but unfortunately it appears to be just a vehicle for Jim Mellon to take and take and take again. I'd have less objection if the share price was riding high and private investors were seeing the benefits too but we're not. It stinks in my opinion. He should allow the company to grow and mature before taking his cut. News like this just kills the share price and puts off potential investors.
Dominicusbenacus, yes it is a good thing that Jim Mellonm has a seat on the board in a company that ANIC is invested in. This is a positive indeed as you say.
My only point was to highlight the complicated holdings and relationships between the different entities that Jim Mellon is an executive and shareholder of, but without judging it.
Not my best post ever, sorry...
Our Mr Mellon has fired up his share certificate printing press again, I see…..
What do You want to tell US with that commend? Usually it is a good thing that a major investor get a Say and a SEAT on the board in order to influence the activities.
In 2019, Mr. Mellon co-founded Agronomics and now sits on the board of three of Agronomics’ portfolio companies including Liberation Labs, Meatly and Clean Food Group.
Is it only Jim and friends comfortable with how this is going all for them and nowt for us?
No buyback info on when happening which is not a good look.
Recived general email from Meatly
Summary:
Invitation to participate in Series A fund raise
conducted nutritional tests on product - contains all amino acides and has similar nutritional profile to checken
Boosted yield of product produced
Improvement in cost reduction of product
In the process of conducting kitchen and feeding trials before the official launch in the coming months
regards
PD
BEP of around 20p here. I recently topped up but at my max allocation for the moment.
Impressive indeed. Positive news in the pet food sector when coupled with what's going on with Meatly. Hope to hear more about Meatly's progress in the near future as well.
Right dazzle. 40p would do me nicely.
Ha ha, let's hope so dazzle! Seems crazy that they would go to the effort of preparing for it and announcing it, only to not bother?!
With the share buyback program drawing to a close on March 29, there's still a chance that we will see the strategic deployment of the full £3.0 million. This could act as a potent afterburner, propelling the stock price back to the revered summits of its past glory.
Or perhaps not.
Interesting press release on Bond Ped Food today. Especially impressive to see their ability to collaboratie with & produce for a true industry leader
A better question is how to raise this question in a way that it will actually has an impact. I was wondering why no podcast really stresses on this points yet. Buy back program not executed still - why?, no insider purchases in spite of ANIC continuously promoting the huge discount to NAV - Why? (don't trust the NAV?), or withdrawing significant amount of money and not making the services of shellbay transparent -- What have been the services?, installing Jim Mellon as a Executive Chairman...-- Why?
So there are lots of questions, and I would be curious how all of these can be addressed in an effective way.
Why is there so many high consultancy fees £3.4millionand £4.6 million and as well as gifted shares to shellbay? Also a lot seems to be taken from the company be Mellon and Eke. Even through Shellbay. Can someone explain please.
Good review of partnership between Fortnum & Masons and Ivy Farms to produce cultured meat surround for Scotch egg. The article also suggests that the Government has advised that it expects the FSA to approve cultured meat this year.
https://www.theguardian.com/food/2024/feb/03/a-very-cultured-snack-trying-fortnum-and-masons-scotch-egg-with-lab-grown-meat
PD
Nothing really new in this interview:
https://www.share-talk.com/zak-mir-talks-to-anthony-chow-co-founder-of-agronomics-aimanic-limited/
I wonder about the reference to end of March 2024. Coincidentally that is when the buyback period is meant to expire. There may be hope yet for a solid amount of buyback….possibly….maybe…
Thanks for that Dom!
I do have access:
Basically, nothing new. Also, they are not independent research. Canaccord is intertwined with Agronomics.
A little excerpt from the summary of the report:
ANIC's portfolio companies, BlueNalu, All G Foods, and Onego Bio, should all demonstrate regulatory success in 2H24, validating and de-risking the portfolio as a whole.
Valuation: We remain BUYers with an unchanged target price of 20p. We reiterate BUY at 20p. We continue to base our value on our expected NAV as of end March 2024.
hi,
yes, i guess we are all waiting to see if/how many shares they are buying back and how this influences shareholding and share price....havent heard about specific timeline though.
also anyone with access to this?
https://*********************/companies/uk/asset-management/agronomics-limited/research/canaccord-genuity/portfolio-visit-clean-food-group-for-sustainable-palm-oil/85_44b76aed-534a-4f40-8a93-7cbf30fdf900/10189bb1-e826-4854-a0d6-ce6f229f280d
Will the buy back program ever be executed?
It is difficult to comprehend that Agronomics announces the buy back program, yet no action has been taken in order to make use of the huge discount to NAV.
Anybody knows more?
Bought 27th October 2020 @ 6p, Sold 27th December 2020 @ 9.76p.
Not looked since .
Topped out after at 37p 5th May 2021 wow.
Fell back to 9p 2nd November 2023 wow.
AIM LOL
Solar Foods: Fazer introduces a unique chocolate snack bar, Fazer Taste the Future, powered by Solein®, in Singapore. Solein® is created out of thin air and Singapore is the first in the world with a novel food approval for the ingredient. The snack bar is available as a limited edition at selected shops in Singapore from 18 January 2024.
https://www.fazergroup.com/media/news-page/?id=4728275